-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Checkpoint Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2017 to Q2 2024.
- Checkpoint Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -673 %, a 41% decline year-over-year.
- Checkpoint Therapeutics, Inc. annual Return On Assets for 2023 was -950 %, a 317% decline from 2022.
- Checkpoint Therapeutics, Inc. annual Return On Assets for 2022 was -228 %, a 146% decline from 2021.
- Checkpoint Therapeutics, Inc. annual Return On Assets for 2021 was -92.8 %, a 31.8% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)